Low anti‐SARS‐CoV‐2 S antibody levels predict increased mortality and dissemination of viral components in the blood of critical COVID‐19 patients
M Martin‐Vicente, R Almansa, I Martínez… - Journal of internal …, 2022 - Wiley Online Library
Abstract Background Anti‐SARS‐CoV‐2 S antibodies prevent viral replication. Critically ill
COVID‐19 patients show viral material in plasma, associated with a dysregulated host …
COVID‐19 patients show viral material in plasma, associated with a dysregulated host …
[PDF][PDF] Low anti-SARS-CoV-2 S antibody levels predict increased mortality and dissemination of viral components in the blood of critical COVID-19 patients
M Martin-Vicente, R Almansa, I Martínez, AP Tedim… - 2021 - researchgate.net
Martin-Vicente M, Almansa R, Martínez I, Tedim AP, Bustamante E, Tamayo L, et al. Low anti-
SARS-CoV-2 S antibody levels predict increased mortality and dissemination of viral …
SARS-CoV-2 S antibody levels predict increased mortality and dissemination of viral …
Low anti‐SARS‐CoV‐2 S antibody levels predict increased mortality and dissemination of viral components in the blood of critical COVID‐19 patients.
M Martin‐Vicente, R Almansa… - Journal of Internal …, 2022 - search.ebscohost.com
Abstract Background: Anti‐SARS‐CoV‐2 S antibodies prevent viral replication. Critically ill
COVID‐19 patients show viral material in plasma, associated with a dysregulated host …
COVID‐19 patients show viral material in plasma, associated with a dysregulated host …
Low anti-SARS-CoV-2 S antibody levels predict increased mortality and dissemination of viral components in the blood of critical COVID-19 patients.
M Martin-Vicente, R Almansa, I Martínez… - Journal of Internal …, 2021 - europepmc.org
Background Anti-SARS-CoV-2 S antibodies prevent viral replication. Critically ill COVID-19
patients show viral material in plasma, associated with a dysregulated host response. If …
patients show viral material in plasma, associated with a dysregulated host response. If …
Low anti-SARS-CoV-2 S antibody levels predict increased mortality and dissemination of viral components in the blood of critical COVID-19 patients
M Martin-Vicente, R Almansa… - Journal of internal …, 2022 - pubmed.ncbi.nlm.nih.gov
Background Anti-SARS-CoV-2 S antibodies prevent viral replication. Critically ill COVID-19
patients show viral material in plasma, associated with a dysregulated host response. If …
patients show viral material in plasma, associated with a dysregulated host response. If …
[PDF][PDF] Low anti-SARS-CoV-2 S antibody levels predict increased mortality and dissemination of viral components in the blood of critical COVID-19 patients
M Martin-Vicente, R Almansa, I Martínez, AP Tedim… - 2021 - idibapsrespiratoryresearch.org
Martin-Vicente M, Almansa R, Martínez I, Tedim AP, Bustamante E, Tamayo L, et al. Low anti-
SARS-CoV-2 S antibody levels predict increased mortality and dissemination of viral …
SARS-CoV-2 S antibody levels predict increased mortality and dissemination of viral …
Low anti-SARS-CoV-2 s antibody levels predict increased mortality and dissemination of viral components in the blood of critical COVID-19 patients.
M Martin-Vicente, R Almansa, I Martínez, AP Tedim… - 2021 - cabidigitallibrary.org
Abstract Background: Anti-SARS-CoV-2 S antibodies prevent viral replication. Critically ill
COVID-19 patients show viral material in plasma, associated with a dysregulated host …
COVID-19 patients show viral material in plasma, associated with a dysregulated host …
[HTML][HTML] Low anti‐SARS‐CoV‐2 S antibody levels predict increased mortality and dissemination of viral components in the blood of critical COVID‐19 patients
M Martin‐Vicente, R Almansa, I Martínez… - Journal of Internal …, 2022 - ncbi.nlm.nih.gov
Background Anti‐SARS‐CoV‐2 S antibodies prevent viral replication. Critically ill COVID‐19
patients show viral material in plasma, associated with a dysregulated host response. If …
patients show viral material in plasma, associated with a dysregulated host response. If …
Low anti-SARS-CoV-2 S antibody levels predict increased mortality and dissemination of viral components in the blood of critical COVID-19 patients.
M Martin-Vicente, R Almansa, I Martínez… - Journal of Internal …, 2021 - europepmc.org
Background Anti-SARS-CoV-2 S antibodies prevent viral replication. Critically ill COVID-19
patients show viral material in plasma, associated with a dysregulated host response. If …
patients show viral material in plasma, associated with a dysregulated host response. If …
Low anti-SARS-CoV-2 S antibody levels predict increased mortality and dissemination of viral components in the blood of critical COVID-19 patients
M Martin-Vicente, R Almansa… - Journal of internal …, 2022 - pubmed.ncbi.nlm.nih.gov
Background Anti-SARS-CoV-2 S antibodies prevent viral replication. Critically ill COVID-19
patients show viral material in plasma, associated with a dysregulated host response. If …
patients show viral material in plasma, associated with a dysregulated host response. If …